Ting Bao

Ting Bao

Medical Oncologist

Harvard Medical School

USA, Boston

Present Title & Affiliation

  • Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA
  • Physician, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • Associate Physician, Medical Oncology, Brigham and Women’s Hospital, Boston, MA, USA
  • Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living, Dana-Farber Cancer Institute
  • Faculty Member, Dana-Farber/Harvard Cancer Center (DF/HCC)
YearsPosition / DegreeField / NotesInstitution / Location

Education
1999BAEnglish & BiochemistryWellesley College, Wellesley, MA
2003MDMedicineJohns Hopkins School of Medicine, Baltimore, MD
2013MSClinical ResearchUniversity of Maryland, Baltimore, MD

Postdoctoral Training

2003–2006

ResidentInternal MedicineJohns Hopkins Bayview Medical Center, Baltimore, MD

2006–2009

Clinical FellowMedical OncologyJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Faculty Academic

2009–2014

Assistant ProfessorMedicineUniversity of Maryland, Baltimore, MD

2018–2021

Assistant ProfessorMedicineWeill Cornell Medical College, Cornell University, NY

2021–2023

Associate ProfessorMedicineWeill Cornell Medical College

2023–2024

Member of the Faculty

2024–

Associate ProfessorMedicineHarvard Medical School

Hospital / Affiliated
2009–2014Assistant Attending PhysicianMedical OncologyGreenebaum Cancer Center, University of Maryland
2014–2021Assistant MemberIntegrative MedicineMemorial Sloan Kettering Cancer Center (MSKCC), NY
2021–2023Associate MemberIntegrative MedicineMSKCC
2023–PhysicianMedical OncologyDana-Farber Cancer Institute (DFCI), Boston, MA
2024–Associate PhysicianMedical OncologyBrigham and Women’s Hospital (BWH), Boston, MA

Major Leadership Roles

2017–2023DirectorIntegrative Breast OncologyMSKCC
2020Course Co-DirectorOncology Acupuncture SymposiumMSKCC
2023-Co-DirectorLeonard P. Zakim CenterDFCI

Committee Service

2010–

Symptoms Intervention CommitteeAlliance for Clinical Trials in Oncology

2020

AdvisorCDC Grant Committee — Breast Cancer in Young WomenCDC

Professional Societies

2006–

MemberAmerican Society of Clinical Oncology (ASCO)

2018

Expert PanelASCO Endorsement of SIO GuidelinesASCO

2020

Expert PanelDyspnea GuidelineASCO

2020-2021

Expert PanelSIO–ASCO Cancer Pain GuidelineASCO/SIO
2010-MemberSociety for Integrative Oncology (SIO)
2015–2017TreasurerSIO
2017–2019President-electSIO
2018, 2019Co-ChairSIO Conference PlanningSIO
2019–2021PresidentSIO
2021–2023ChairNomination CommitteeSIO
2021–2023Immediate Past PresidentSIO

2021–

Co-ChairEducation CommitteeSIO

Grant Review Activities
2012ReviewerNursing & Clinical Sciences OverflowNIH
2013Permanent ReviewerSEP: Cancer Therapy ZCA1 RTRB-8 (J1)NCI
2014Permanent ReviewerPain Management, NCCIHNIH
2015Permanent ReviewerSEP ZCA1 RPRB-J M2 SNCI
2016Permanent ReviewerSEP ZAT1 HS (27)NIH
2018Permanent ReviewerSEP ZAT1 VS (11)NCCIH
2020Permanent ReviewerSEP ZRG1 HDM-C-02NIH
2021Permanent ReviewerSEP ZAT1 PS (05)NCCIH
2023ReviewerIntegrative ProgramGateway for Cancer Research

Editorial Activities

#colspan#

Ad hoc ReviewerJCO; JAMA Network Open; Cancer; Breast Cancer Research & Treatment; EJCC; Alzheimer’s Disease
2013–Editorial BoardIntegrative, Alternative & Complementary TherapiesNCI PDQ
2022–Editorial Advisory BoardONCOLOGY® Journal
2024–Senior EditorComprehensive Integrated Oncology, 1st ed.Elsevier

Honors & Awards

2008

Young Investigator AwardASCO Foundation
Postdoctoral Fellowship AwardSusan G. Komen Foundation

2009

Merit AwardExcellent Poster AwardASCO

2017

People’s Choice AwardQuality Improvement FairMSKCC
2024Fellow AwardMajor contributions to SIO and Integrative OncologySIO

Funded Projects

2010–2012

K12 CA126849Acupuncture for BIPNNIH/NCI — PI

2013-2017

R21 CA173263Acupuncture to Prevent CIPN EscalationNIH/NCI — PI

2015-2017

MSKCC QSI FundPatient Education AppMSKCC — PI

2015–2018

PCORIAcupuncture vs CBT-I for InsomniaCo-Investigator

2016-2018

MSKCC Integrative Medicine FundYoga for CIPNPI
MSKCC Integrative Medicine FundAcupuncture for CIPNPI

2016–2020

Department of DefenseAcupuncture for Chronic PainCo-Investigator

2019

R13 CA243566SIO ConferencePI

2019–2021

Frueauff FoundationAcupuncture for CIPNPI

2019–2023

PhilanthropyCIPN ResearchMSKCC-PI
2020–2023R01 CA240417ENHANCE Trial — Acupuncture for Cognitive ImpairmentCo-Investigator

Clinical Supervisory Roles
2009–2014Inpatient AttendingInternal MedicineUMD
2014–2023Inpatient AttendingIntegrative MedicineMSKCC
2014-2023Ambulatory CareIntegrative MedicineMSKCC
2023–Ambulatory PreceptorMedical Oncology, Zakim CenterDFCI

Licensure & Certification
2005–2014Medical LicenseMaryland
2005DiplomateAmerican Board of Medical AcupunctureHelm Institute
2006Board CertificationInternal MedicineABIM
2008Board CertificationMedical OncologyABIM
2014Medical LicenseNew York
2021Medical LicenseNew Jersey
2023Medical LicenseMassachusetts

Clinical Practice
2014–2023Breast Oncology; Integrative MedicineInpatient & AmbulatoryMSKCC
2023-Medical OncologyAmbulatory CareDFCI
2024-Medical OncologyInpatient AttendingBWH

REPORT OF SCHOLARSHIP

Peer-Reviewed Publications – Research Investigations

  1. Bao T. Perspectives. “The Doctor.” Pharos Alpha Omega Alpha Honor Med Soc. 2004;67(2):37–38. PMID: 15214242.
  2. Bao T, Davidson NE. Adjuvant endocrine therapy for premenopausal women with early breast cancer. Breast Cancer Res. 2007;9(6):115. PMID: 18190722; PMCID: PMC2246185.
  3. Bao T, Davidson NE. Maintaining bone health in early-stage breast cancer patients on aromatase inhibitors. J Oncol Pract. 2007;3(6):323–325. PMID: 20859389; PMCID: PMC2793755.
  4. Bao T, Ye X, Skinner J, et al. Magnetic acupressure for analgesia during bone marrow aspiration/biopsy: a randomized, blinded, controlled trial. J Pain Symptom Manage. 2011;41(6):995–1002. PMID: 21306863.
  5. Bao T, Blackford AL, Stearns V. Effect of simvastatin on anastrozole pharmacokinetics. Breast Cancer Res Treat.2012;131(2):709–711. PMID: 22089963.
  6. Mahmood U, Morris C, Neuner G, et al. Breast-conservation therapy vs mastectomy in young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1387–1393. PMID: 22300561.
  7. Bao T, Cai L, Giles JT, et al. Acupuncture for aromatase inhibitor–induced musculoskeletal symptoms: double-blind RCT. Breast Cancer Res Treat. 2013;138(1):167–174. PMID: 23393007; PMCID: PMC3594526.
  8. Bao T, Cai L, Snyder C, et al. Patient-reported outcomes from a double-blind RCT of acupuncture for AI-induced musculoskeletal symptoms. Cancer. 2014;120(3):381–389. PMID: 24375332; PMCID: PMC3946917.
  9. Bhatnagar B, Gilmore S, Goloubeva O, et al. Chemotherapy dose reduction due to CIPN in breast cancer: single-center experience. Springerplus. 2014;3:366. PMID: 25089251; PMCID: PMC4117856.
  10. Bao T, Goloubeva O, Pelser C, et al. Pilot study of acupuncture for bortezomib-induced peripheral neuropathy in multiple myeloma. Integr Cancer Ther. 2014;13(5):396–404. PMID: 24867959; PMCID: PMC4562796.
  11. Bao T, Basal C, Seluzicki C, et al. Long-term CIPN in breast cancer survivors: prevalence, risk factors, fall risk. Breast Cancer Res Treat. 2016;159(2):327–333. PMID: 27510185; PMCID: PMC5509538.
  12. Xi D, Bao T, Chen Q, et al. State of the science: Cancer CAM therapeutics—NCI workshop report. J Natl Cancer Inst Monogr. 2017;(52). PMID: 29140484; PMCID: PMC6061228.
  13. Zia FZ, Olaku O, Bao T, et al. NCI Conference on Acupuncture for Oncology Symptom Management. J Natl Cancer Inst Monogr. 2017;(52). PMID: 29140486; PMCID: PMC6061411.
  14. Bao T, Li SQ, Dearing JL, et al. Acupuncture vs medication for pain in breast cancer survivors: cross-sectional study. Acupunct Med. 2018;36(2):80–87. PMID: 29440043; PMCID: PMC6264909.
  15. Kesmodel SB, Goloubeva OG, Rosenblatt PY, et al. Predictors of adherence to adjuvant aromatase inhibitors using the Morisky scale. Am J Clin Oncol. 2018;41(5):508–512. PMID: 27322700.
  16. Bao T, Seidman A, Li Q, et al. Chronic pain in breast cancer survivors: perceptions and experiences. Breast Cancer Res Treat. 2018;169(1):133–140. PMID: 29350307; PMCID: PMC6147242.
  17. Bao T, Iris Zhi W, Vertosick EA, et al. Acupuncture for breast cancer–related lymphedema: RCT. Breast Cancer Res Treat. 2018;170(1):77–87. PMID: 29520533; PMCID: PMC6159216.
  18. Bao T, Li Q, DeRito JL, et al. Barriers to acupuncture use in breast cancer survivors. Integr Cancer Ther.2018;17(3):854–859. PMID: 29338443; PMCID: PMC6142082.
  19. Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of SIO guideline. J Clin Oncol. 2018;36(25):2647–2655. PMID: 29889605.
  20. Bao T, Seidman AD, Piulson L, et al. Acupuncture to reduce CIPN during weekly paclitaxel: Phase IIa trial. Eur J Cancer. 2018;101:12–19. PMID: 30007894; PMCID: PMC6147260.
  21. Mao H, Bao T, Shen X, et al. Fatigue in breast cancer survivors on aromatase inhibitors: prevalence and risk factors. Eur J Cancer. 2018;101:47–54. PMID: 30014974; PMCID: PMC6148367.
  22. Zhi WI, Ingram E, Li SQ, et al. Acupuncture for bortezomib-induced neuropathy: benefits beyond pain. Integr Cancer Ther. 2018;17(4):1079–1086. PMID: 30027756; PMCID: PMC6247555.
  23. Grant SJ, Hunter J, Seely D, et al. Integrative oncology: international perspectives. Integr Cancer Ther.2019;18:1534735418823266. PMID: 30791736; PMCID: PMC7240876.
  24. Im EO, Ji X, Kim S, et al. Challenges in tech-based cancer pain management in Asian American survivors. Comput Inform Nurs. 2019;37(5):243–249. PMID: 31094913; PMCID: PMC6530489.
  25. Basal C, Vertosick E, Gillis TA, et al. Joint pain and falls in women on aromatase inhibitors. Support Care Cancer. 2019;27(6):2195–2202. PMID: 30306326; PMCID: PMC6758909.
  26. Liou KT, Ahles TA, Garland SN, et al. Insomnia and cognitive impairment in breast cancer survivors. JNCI Cancer Spectr. 2019;3(3):pkz041. PMID: 31355357; PMCID: PMC6640530.
  27. Bao T, Deng G, DeMarzo LA, et al. Technology-assisted mind-body intervention in chemotherapy waiting rooms: randomized QI study. JMIR Cancer. 2019;5(2):e13217. PMID: 31697238; PMCID: PMC6873148.
  28. Garland SN, Xie SX, DuHamel K, et al. Acupuncture vs CBT-I for insomnia in cancer survivors: RCT. J Natl Cancer Inst. 2019;111(12):1323–1331. PMID: 31081899; PMCID: PMC6910189.
  29. Zhi WI, Chen P, Kwon A, et al. CIPN in breast cancer survivors: PROs vs quantitative sensory testing. Breast Cancer Res Treat. 2019;178(3):587–595. PMID: 31456070; PMCID: PMC6819268.
  30. Chen C, Li SQ, Bao T, et al. CheeZheng pain-relieving plaster: systematic review. Integr Cancer Ther.2020;19:1534735420918933. PMID: 32880472; PMCID: PMC7485161.
  31. Meghani SH, Rosa WE, Chittams J, et al. Race and insurance predict opioid selection in cancer outpatients. Pain Manag Nurs. 2020;21(1):65–71. PMID: 31501079; PMCID: PMC6980435.
  32. Bao T, Patil S, Chen C, et al. Acupuncture vs sham for CIPN: randomized clinical trial. JAMA Netw Open.2020;3(3):e200681. PMID: 32159808; PMCID: PMC7066475.
  33. Bao T, Zhi I, Baser R, et al. Yoga for CIPN and fall risk: RCT. JNCI Cancer Spectr. 2020;4(6):pkaa048. PMID: 33225208; PMCID: PMC7666827.
  34. Zhi WI, Gentile D, Diller M, et al. Patient-reported outcomes of pain in integrative oncology practice: recommendations. Oncology (Williston Park). 2021;35(1):35–41. PMID: 33443769.
  35. Zhi WI, Baser RE, Kwon A, et al. CIPN characterization with PROs and sensory testing. Breast Cancer Res Treat. 2021;186(3):761–768. PMID: 33507480; PMCID: PMC8406379.
  36. Mao JJ, Liou KT, Baser RE, et al. Electroacupuncture or auricular acupuncture vs usual care for musculoskeletal pain: PEACE RCT. JAMA Oncol. 2021;7(5):720–727. PMID: 33734288; PMCID: PMC7974834.
  37. Yang M, Li SQ, Smith CM, et al. Tibetan herbal pain-relieving plaster for low back pain: systematic review. Biomed Pharmacother. 2021;140:111727. PMID: 34015584; PMCID: PMC9254726.
  38. Zhi WI, Baser RE, Zhi LM, et al. Yoga for CIPN: quality-of-life outcomes. Cancer Med. 2021;10(16):5456–5465. PMID: 34213086; PMCID: PMC8366077.
  39. Desai K, Bao T, Li QS, et al. Interest, barriers, and preferences for yoga among cancer survivors. Support Care Cancer. 2021;29(9):5313–5321. PMID: 33660077; PMCID: PMC9364436.
  40. Blinder VS, Eberle CE, Tran C, et al. Using PRO-based secular controls to study disparities in cancer-related job loss. J Cancer Surviv. 2021;15(5):685–695. PMID: 33106995; PMCID: PMC8071836.
  41. Bao T, Baser R, Chen C, Weitzman M, Zhang YL, Seluzicki C, Li QS, Piulson L, Zhi WI. Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: a randomized clinical trial. Oncologist. 2021 Nov;26(11):e2070–e2078. PMID: 34390283; PMCID: PMC8571772.
  42. Yang M, Baser RE, Li SQ, Hou YN, Chong K, Zhang YL, Hoque I, Bao T, Mao JJ. Tibetan herbal pain-relieving plaster for chronic musculoskeletal pain among cancer survivors: study protocol of a randomized, double-blind, placebo-controlled trial. Front Pharmacol. 2022;13:878371. PMID: 35600872; PMCID: PMC9114465.
  43. Mao JJ, Greenlee H, Bao T, Ismaila N, Bruera E; SIO-ASCO Expert Panel. Integrative medicine for pain management in oncology: Society for Integrative Oncology–ASCO guideline summary and Q&A. JCO Oncol Pract.2022 Oct 19;OP2200622. PMID: 36260826.
  44. Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: Society for Integrative Oncology–ASCO guideline. J Clin Oncol. 2022 Dec 1;40(34):3998–4024. PMID: 36122322.
  45. Zhi WI, Baser RE, Talukder D, Mei YZ, Harte SE, Bao T. Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing. Breast Cancer Res Treat.2023 Feb;197(3):535–545. PMID: 36527520.
  46. Li X, Liou KT, Chimonas S, Bryl K, Wong G, Spiguel E, Li SQ, Garland SN, Bao T, Mao JJ. Addressing cancer-related fatigue through sleep: secondary analysis of a randomized trial comparing acupuncture and cognitive behavioral therapy for insomnia. Integr Med Res. 2023 Mar 12;12(1):100922. PMID: 36843902; PMCID: PMC9944506.
  47. Li X, Bao T, Garland SN, Li SQ, Yu J, Li Y, Mao JJ. Does expectancy affect insomnia treatment response in cancer survivors receiving acupuncture and cognitive behavioral therapy? J Cancer Surviv. 2023 Jun;17(3):826–835. PMID: 36462115.
  48. Zhi WI, Dreyfus N, Lessing A, Galantino M, Piulson L, Kot KL, Li S, Bao T. Patient characteristics associated with chemotherapy-induced peripheral neuropathy severity in a phase II clinical trial: a retrospective analysis. Oncologist.2023 Jul 5;28(7):604–608. PMID: 36972359; PMCID: PMC10322124.
  49. Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, … Bao T, … Lustberg MB, Accordino MK, Shah DP; COVID-19 and Cancer Consortium. Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a CCC19 cohort study. eLife. 2023 Oct 17;12:e82618. PMID: 3784664; PMCID: PMC10637772.
  50. Bao T, Zhi WI, Baser RE, Li QS, Weitzman M, Gillespie EF, Robson M, Mao JJ. Electro-acupuncture versus battlefield auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: subgroup analysis of a randomized clinical trial. Breast Cancer Res Treat. 2023 Nov;202(2):287–295. PMID: 37612534.
  51. Im EO, Chee W, Paul S, Choi MY, Kim SY, Yeo S, Ulrich CM, Schapira MM, Nguyen GT, Meghani S, Mao JJ, Ma G, Inouye J, Deatrick JA, Shin D, Bao T. Five dimensions of needs for help: efficacy of a technology-based intervention among Asian American breast cancer survivors. J Cancer Educ. 2024 Jun;39(3):335–348. PMID: 38594385; PMCID: PMC11186045.
  52. Saint K, Nemirovsky D, Lessing A, Chen Y, Yang M, Underwood WP, Galantino ML, Jones LW, Bao T. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Res Treat. 2024 Aug;206(3):667–675. PMID: 38713289.
  53. Saint K, Paul T, Patterson C, Yang M, Bao T, Galantino ML. Assessing fidelity in yoga interventions for chemotherapy-induced peripheral neuropathy: decision-making to enhance protocol adherence. Integr Cancer Ther.2024;23:15347354241261373. PMID: 39066651; PMCID: PMC11283657.
  54. Bao T, Lopez G, Crudup T, Lopez AM, Paller CJ, Gowin K, Mehta A, Witt CM, Zick SM, Balneaves LG.Advancing integrative oncology: the Society for Integrative Oncology Education Committee’s journey and vision. J Integr Complement Med. 2024 Aug 26. [Online ahead of print.] PMID: 39180433.
  55. Lu W, Giobbie-Hurder A, Tanasijevic A, Kassis SB, Park SH, Jeong YJ, Shin IH, Yao C, Jung HJ, Zhu Z, Bao C, Bao T, Yang E, Bierer BE, Ligibel JA. Acupuncture for hot flashes in hormone receptor–positive breast cancer: pooled analysis of individual patient data from parallel randomized trials. Cancer. 2024 Sep 15;130(18):3219–3228. PMID: 38924035.
  56. Yang M, Shao C, Shao C, Saint K, Wayne PM, Bao T. Tai Chi for balance and postural control in people with peripheral neuropathy: a scoping review. Complement Ther Med. 2024 Nov;86:103089. PMID: 39326640.
  57. Yang M, Shao C, Shao C, Saint K, Gupta M, Caputo R, Galantino ML, Harte S, Bao T. A retrospective cohort study on the preliminary efficacy of massage therapy for chemotherapy-induced peripheral neuropathy among cancer patients. Integr Cancer Ther. 2025;24:15347354251323258. PMID: 39995182; PMCID: PMC11863244.
  58. Im EO, Chee W, Paul S, Kim SY, Choi MY, Mao JJ, Nguyen GT, Schapira MM, Ulrich CM, Yeo S, Deatrick JA, Inouye J, Ma G, Meghani S, Shin D, Bao T. Multiple dimensions of quality of life among Asian American breast cancer survivors: impact of a technology-based program. Breast. 2025 Aug;82:104490. PMID: 40359896; PMCID: PMC12139231.
  59. Im EO, Chee W, Paul S, Kim SY, Choi MY, Deatrick J, Inouye J, Ma G, Mao J, Meghani S, Nguyen GT, Schapira M, Ulrich C, Yeo SA, Bao T, Shin D. Technology-based educational intervention and multiple domains of symptom experience in Asian American breast cancer survivors. J Cancer Educ. 2025 May 15. [Online ahead of print.] PMID: 40372611.

Other Peer-Reviewed Publications

  1. Bao T, Smith BD, Karp JE. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation. Clin Adv Hematol Oncol. 2005 Apr;3(4):287–296, 302. PMID: 16167001.
    Bao T, Prowell T, Stearns V. Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond. Am J Ther.2006;13(4):337–348. PMID: 16858170.
  2. Bao T, Davidson NE. Gene expression profiling of breast cancer. Adv Surg. 2008;42:249–260. PMID: 18953822; PMCID: PMC2775529.
  3. Bao T. Use of acupuncture in the control of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw.2009 May;7(5):606–612. PMID: 19460284.
  4. Bao T, Fetting J, Mumford L, Zorzi J, Shahverdi K, Jeter S, Herlong F, Stearns V, Lee L. Severe prolonged cholestatic hepatitis caused by exemestane. Breast Cancer Res Treat. 2010 Jun;121(3):789–791. PMID: 19834799; PMCID: PMC3085997.
  5. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Res Treat. 2011;2011:920807. PMID: 22110934; PMCID: PMC3199913.
  6. Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol. 2011 May;125(1–2):13–22. PMID: 21335088; PMCID: PMC3104073.
  7. Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, Bao T, Bily L, Tuppo CM, Williams AF, Karadibak D. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015 May 21;CD003475. PMID: 25994425; PMCID: PMC4966288.
  8. Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol. 2016 Feb;98:325–334. PMID: 26652982; PMCID: PMC4727999.
  9. Bao T, Peppone LJ, Robinson P. Addressing the unintentional consequences of cancer therapy with novel integrative therapeutics. Am Soc Clin Oncol Educ Book. 2018 May 23;38:822–828. PMID: 30231327.
  10. Deng G, Bao T, Mao JJ. Understanding the benefits of acupuncture treatment for cancer pain management. Oncology (Williston Park). 2018 Jun;32(6):310–316. PMID: 29940063.
  11. Gentile D, Beeler D, Wang XS, Ben-Arye E, Zick SM, Bao T, Carlson LE, Ghelman R, Master V, Tripathy D, Zhi WI. Cancer-related fatigue outcome measures in integrative oncology: evidence for practice and research recommendations. Oncology (Williston Park). 2022 May 9;36(5):276–287. PMID: 35576178.
  12. Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: Society for Integrative Oncology–ASCO Guideline. J Clin Oncol. 2022 Dec 1;40(34):3998–4024. PMID: 36122322.
  13. Bao T, Greenlee H, Lopez AM, Kadro ZO, Lopez G, Carlson LE. How to make evidence-based integrative medicine a part of everyday oncology practice. Am Soc Clin Oncol Educ Book. 2023;43:e389830. PMID: 37200595.
  14. Shainhouse J, Hwang PSY, Fontes M, Bao T. Integrative medicine in breast cancer survivorship care. Ann Palliat Med. 2025 May;14(3):283–394. PMID: 40511571.

Non-Peer-Reviewed Publications, Chapters & Editorials

  1. Bao T, Davidson N. Genetic profiling of breast cancer. In: Cameron JL, ed. Advances in Surgery. 2008;42:249–260.
  2. Bao T. Commentary on the Cochrane review of P6 acupuncture point stimulation for postoperative nausea and vomiting. Explore (NY). 2011;7(4):263–264. PMID: 21724162.
  3. Bao T, Lao L, Bardia A. Cancer pain control with Traditional Chinese Medicine. In: Cho WCS, ed. Supportive Cancer Care with Chinese Medicine. Springer, 2010:169–225.
  4. Wang L, Bao T. Acupuncture for cancer patients: practice and research. In: Chen LL, Cheng TO, eds. Acupuncture in Modern Medicine. IntechOpen, 2013:277–297.
  5. Bao T. Integrative approaches to symptom management in breast cancer patients. In: Tkaczuk KHR, Kesmodel SB, Feigenberg SJ, eds. Handbook of Breast Cancer and Related Breast Diseases. Demos Medical Publishing, 2016:264–285.
  6. Carlson LE, Bao T, Balneaves LG. Methodology flaws and implications of a complementary medicine study. JAMA Oncol. 2019 Mar 1;5(3):432. PMID: 30676624.
  7. MacLeod J, Lopez G, Bao T. Palliative care in integrative oncology. J Altern Complement Med. 2020 Sep;26(9):766–767. PMID: 32946264.
  8. Bao T, Mao J. Complementary, alternative, and integrative therapies in cancer care. In: DeVita VT, Rosenberg SA, Lawrence TS, eds. Cancer: Principles and Practice of Oncology. 2023:1872–1877.

Case Reports

  1. Bao T. The Doctor. Pharos. 2004;67:37–38.
  2. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy. Pain Res Treat. 2011;2011:920807. PMID: 22110934; PMCID: PMC3199913.
  3. Bhatnagar B, Pelser C, Gilmore S, Tait N, Bao T. Acupuncture and low-dose gabapentin effectively treat paclitaxel-induced peripheral neuropathy and prevent chemotherapy dose reduction. Altern Integ Med. 2013;2:126. doi:10.4172/2327-5162.1000126.

Abstracts, Posters & Conference Presentations

  1. Bao T, Patil S, Zhi WI, Chen P, Li Q, Piulson L, Chen C, Blinder V, Seidman A, Vahdat L, Sugarman S, Robson M, Mao JJ.
    Acupuncture for persistent CIPN symptoms in solid tumor survivors: a pilot RCT.
    SIO 2019 International Conference, New York, NY. (Oral – Best of SIO)
  2. Zhi I, Wang R, Seluzicki C, Bradfield A, Bao T.
    Reducing the knowledge gap in integrative medicine among breast oncology professionals.
    SABCS 2022, San Antonio, TX. (Poster)
  3. Bao T, Zhi I, Baser R, Li Q, Robson M, Mao JJ.
    Effectiveness of electroacupuncture vs auricular acupuncture for chronic musculoskeletal pain in breast cancer survivors.
    SABCS 2022, San Antonio, TX. (Spotlight Poster Discussion)
  4. Bao T, Feng A, Lu W, Zhi I, Yang M.
    Characteristics of acupuncture intervention for CIPN prevention: scoping review.
    Society for Acupuncture Research International Conference 2025, Newport Beach, CA. (Poster 21)